After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Stoke Therapeutics Inc is $698.67M. A total of 0.77 million shares were traded on the day, compared to an average of 558.92K shares.
In the most recent transaction, Ticho Barry sold 10,000 shares of STOK for 12.06 per share on Oct 01 ’24. After the transaction, the CHIEF MEDICAL OFFICER now owns 2,485 company shares. In a previous transaction on Sep 19 ’24, Skorpios Trust sold 1,937,500 shares at 14.05 per share. STOK shares that 10% Owner owns now total 8,906,181.
Among the insiders who bought shares, Blue Horizon E LTD acquired of 1,937,500 shares on Sep 19 ’24 at a per-share price of $15.22. In another insider transaction, Ticho Barry sold 10,000 shares at $14.95 per share on Sep 03 ’24. Company shares held by the CHIEF MEDICAL OFFICER now total 2,485.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, STOK has a high of $17.58 and a low of $3.35.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. STOK’s latest balance sheet shows that the firm has $219.81M in Cash & Short Term Investments as of fiscal 2021. There were $1.51M in debt and $17.14M in liabilities at the time. Its Book Value Per Share was $4.64, while its Total Shareholder’s Equity was $217.78M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for STOK is Buy with a score of 4.67.
